Structure of The Interacting-Heads Motif in Myosin Filaments and Molecules
Project Number5R01AR072036-05
Contact PI/Project LeaderCRAIG, ROGER W
Awardee OrganizationUNIV OF MASSACHUSETTS MED SCH WORCESTER
Description
Abstract Text
The interacting-heads motif (IHM) is a configuration of myosin heads in relaxed thick filaments of
muscle, in which ATP turnover and actin binding are inhibited by the interaction of each head with the other. In
a dramatic development in the field, this motif has become recognized as a fundamental feature of normal
muscle relaxation and contraction, through its regulation of thick filament activity. In addition to its role in thick
filaments, the IHM also underlies the structure of single molecules of myosin II in almost all types of animal
cell. In this monomeric form, the myosin tail folds up, forming a compact molecule, in which ATPase activity is
again inhibited by similar head-head interactions. The IHM appears to play two key roles in the body. In thick
filaments, it contributes to energy conservation in the relaxed state of muscle. As a monomer, it functions as a
storage form of myosin whose compact form facilitates transport to its site of filament assembly. These critical
new findings are the motivation for this application: our goal is to elucidate the structure of this fundamental
regulatory motif in skeletal muscle thick filaments and single myosin molecules, thus illuminating how it
functions. We will do this using state-of-the-art cryo-EM and 3D reconstruction techniques, studying selected
model systems and integrating the information gained from each.
In Aim 1 we will determine the 3D structure of the IHM in native thick filaments using novel cryo-EM
technology that is currently revolutionizing structural biology. Using tarantula skeletal muscle filaments, the
most stable species known, we will determine at better than 10 Å resolution the interactions between the two
heads, and between the heads and the tail, that create the IHM. With help from the insights gained, we will
determine the structure of frog skeletal thick filaments, the most stable vertebrate filament. And we will build on
this information to determine the structure of the IHM in (less stable) mammalian thick filaments. In Aim 2, we
will determine the 3D structure of the IHM in isolated myosin molecules, using three complementary systems:
smooth muscle myosin as the most stable single molecule, which will provide the highest resolution; tarantula
myosin as a direct link to the filament structure in Aim 1, aiding its interpretation; and mammalian myosin,
which will reveal the structure in vertebrate skeletal muscle. We will also examine molecules in which putative
head interaction sites have been mutated, to test their importance in formation of the IHM. In Aim 3, we will use
single molecule EM to test the hypothesis that disease mutations in the head region of skeletal myosin impact
the stability of the IHM.
The IHM is now recognized as a fundamental motif of normal muscle function. Our proposal will
elucidate its interactions, providing new insights into the structural basis of contraction and relaxation, and of
the potential impact of disease mutations on these functions.
Public Health Relevance Statement
Skeletal muscle is built from thick (myosin) and thin (actin) protein filaments whose interaction
underlies contraction and our ability to move. In relaxed muscle the two heads of each myosin molecule
interact with each other, switching off their activity, thus aiding relaxation. We will use electron microscopy to
elucidate new details of these head interactions, which are required for proper relaxation. The results will aid
our understanding of normal muscle function, and of its development and repair.
National Institute of Arthritis and Musculoskeletal and Skin Diseases
CFDA Code
846
DUNS Number
603847393
UEI
MQE2JHHJW9Q8
Project Start Date
14-July-2017
Project End Date
31-May-2023
Budget Start Date
01-June-2021
Budget End Date
31-May-2023
Project Funding Information for 2021
Total Funding
$404,967
Direct Costs
$255,127
Indirect Costs
$149,840
Year
Funding IC
FY Total Cost by IC
2021
National Institute of Arthritis and Musculoskeletal and Skin Diseases
$404,967
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01AR072036-05
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01AR072036-05
Patents
No Patents information available for 5R01AR072036-05
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01AR072036-05
Clinical Studies
No Clinical Studies information available for 5R01AR072036-05
News and More
Related News Releases
No news release information available for 5R01AR072036-05
History
No Historical information available for 5R01AR072036-05
Similar Projects
No Similar Projects information available for 5R01AR072036-05